U.S. markets close in 4 hours 10 minutes
  • S&P 500

    3,690.40
    +43.11 (+1.18%)
     
  • Dow 30

    29,448.21
    +313.22 (+1.08%)
     
  • Nasdaq

    10,946.99
    +117.49 (+1.08%)
     
  • Russell 2000

    1,698.29
    +35.78 (+2.15%)
     
  • Crude Oil

    80.69
    +2.19 (+2.79%)
     
  • Gold

    1,661.10
    +24.90 (+1.52%)
     
  • Silver

    18.62
    +0.29 (+1.57%)
     
  • EUR/USD

    0.9667
    +0.0070 (+0.73%)
     
  • 10-Yr Bond

    3.7730
    -0.1910 (-4.82%)
     
  • GBP/USD

    1.0809
    +0.0078 (+0.73%)
     
  • USD/JPY

    144.2530
    -0.5380 (-0.37%)
     
  • BTC-USD

    19,405.91
    -690.85 (-3.44%)
     
  • CMC Crypto 200

    442.76
    +13.98 (+3.26%)
     
  • FTSE 100

    7,002.59
    +18.00 (+0.26%)
     
  • Nikkei 225

    26,173.98
    -397.89 (-1.50%)
     

Why Virax Biolabs Stock Plummeted 74% On Friday

·2 min read

Shares of Virax Biolabs (NASDAQ: VRAX) dropped 74% on Friday. The biotech company, which specializes in the detection and treatment of viral diseases, just began trading on the NASDAQ on July 21 after an initial public offering (IPO).